Aquestive Therapeutics Inc (NAS:AQST)
$ 3.22 -0.05 (-1.53%) Market Cap: 293.14 Mil Enterprise Value: 236.98 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 55/100

Q3 2022 Aquestive Therapeutics Inc Earnings Call Transcript

Nov 02, 2022 / 12:00PM GMT
Release Date Price: $0.84 (-1.81%)
Operator

Good morning, and welcome to the Aquestive Therapeutics Third Quarter 2022 Conference Call. (Operator Instructions) As a reminder, this call will be recorded.

I would now like to introduce your host for today's conference call, Bennett Watson of Westwicke Investor Relations. You may begin.

Bennett Watson;Westwicke Investor Relations

Thank you, operator. Good morning, and welcome to today's call. On today's call, I am joined by Dan Barber, Chief Executive Officer; and Ernie Toth, Chief Financial Officer, who are going to provide an overview of recent business developments and performance for the third quarter of 2022, followed by a Q&A session. During the Q&A session, the team will be joined by Dr. Steve Wargacki, Vice President of R&D; Ken Truitt, Chief Medical Officer; and Ken Marshall, Chief Commercial Officer.

As a reminder, the company's remarks today correspond to the earnings release that was issued after market close yesterday. In addition, a recording of today's call will be made available on Aquestive's website

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot